Neutrophil-derived hydrogen peroxide (H2O2) is believed to play an important role in the pathogenesis of vascular injury and pulmonary edema. H2O2 time-and dose-dependently increased the hydraulic conductivity and decreased the selectivity of an endothelial cell monolayer derived from porcine pulmonary arteries. Effects of H2O2 on endothelial permeability were completely inhibited by adenylate cyclase activation with 10(-12) M cholera toxin or 0.1 microM forskolin. 10(-8) M Sp-cAMPS, a cAMP-dependent protein kinase A agonist, was similarly effective. The phosphodiesterase (PDE) inhibitors motapizone (10(-4) M), rolipram (10(-6) M), and zardaverine (10(-8) M), which specifically inhibit PDE-isoenzymes III, IV, and III/IV potently blocked H2O2-induced endothelial permeability when combined with 10(-6) M prostaglandin E1. Overall cellular cAMP content and inhibition of H2O2 effects on endothelial permeability were poorly correlated. H2O2 exposure resulted in a rapid and substantial decrease in endothelial cAMP content. The analysis of the PDE isoenzyme spectrum showed high activities of isoenzymes II, III, and IV in porcine pulmonary endothelial cells. The data suggest that adenylate cyclase activation/PDE inhibition is a powerful approach to block H2O2-induced increase in endothelial permeability. This concept appears especially valuable when endothelial PDE isoenzyme pattern and PDE inhibitor profile are matched optimally. Neutrophil-derived hydrogen peroxide (H202) is believed to play an important role in the pathogenesis of vascular injury and pulmonary edema. H202 time-and dose-dependently increased the hydraulic conductivity and decreased the selectivity of an endothelial cell monolayer derived from porcine pulmonary arteries. Effects of H202 on endothelial permeability were completely inhibited by adenylate cyclase activation with 10-12 M cholera toxin or 0.1 juM forskolin. 10' M Sp-cAMPS, a cAMP-dependent protein kinase A agonist, was similarly effective. The phosphodiesterase (PDE) inhibitors motapizone (10'-M), rolipram (10-' M), and zardaverine (10-8 M), which specifically inhibit PDE-isoenzymes III, IV, and III/IV potently blocked H202-induced endothelial permeability when combined with 10' M prostaglandin El. Overall cellular cAMP content and inhibition of H202 effects on endothelial permeability were poorly correlated. H202 exposure resulted in a rapid and substantial decrease in endothelial cAMP content. The analysis of the PDE isoenzyme spectrum showed high activities of isoenzymes II, III, and IV in porcine pulmonary endothelial cells. The data suggest that adenylate cyclase activation/PDE inhibition is a powerful approach to block H202-induced increase in endothelial permeability. This concept appears especially valuable when endothelial PDE isoenzyme pattern and PDE inhibitor profile are matched optimally. (J.
Introduction
The endothelium provides a major permeability barrier of the vessel wall. In the course ofinflammation, polymorphonuclear leukocytes may damage endothelial cells resulting in an increased vascular permeability. Hydrogen peroxide (H202) is an important polymorphonuclear leukocyte-derived mediator of endothelial cell injury (1) (2) (3) . Intracellular events after H202 exposure are manyfold and include a drop in ATP, NADH, and glutathione levels, an increased hydrolysis ofinositol phos-Receivedfor publication 4 March 1992 and in revisedform 20 August 1992. pholipids, as well as an enhancement of the intracellular Ca2" concentration (4) (5) (6) (7) (8) (9) . As a result endothelial permeability may increase, possibly caused by Ca2"-mediated endothelial cell contraction (10) (11) (12) .
Studies using isolated lungs and endothelial cell monolayers grown on filter membranes have shown a protective effect ofcAMP-increasing reagents on increased vascular permeability (13) (14) (15) (16) (17) (18) (19) . Endothelial adenylate cyclase can be stimulated by (3-receptor agonists or experimentally by cholera toxin or the diterpene forskolin (20) . In addition, 3-isobutyl-1-methylxanthine, an unselective and weak inhibitor of phosphodiesterases (PDE),' has been used frequently to increase cellular cAMP content (21 ) .
Five PDE isoenzymes have been identified so far in mammalian tissue (22) . The PDE classification is based on substrate specificity and regulation characteristics (22). Selective inhibitors are known for most ofthe PDE isoenzymes (PDE III selective motapizone, PDE IV selective rolipram, and PDE III/ IV dual selective zardaverine) (22) (23) (24) . PDE isoenzyme pattern differs among tissues and cells. For endothelial cells, the expression ofat least two PDE isoenzymes have been described (25, 26) . The identification of class-specific PDE inhibitors probably will allow a more efficient intervention in different target tissues in many pathophysiological situations (22, 23) .
In the present study, H202-induced alterations of endothelial cell monolayer permeability were examined. Using this well-characterized system, effects of isoenzyme specific PDE inhibitors were studied. In addition, the PDE isoenzyme pattern in pig pulmonary artery endothelial cells was analyzed and correlated to the functional studies.
Methods
Materials. Tissue culture plasticware was obtained from Becton-Dickinson (Heidelberg, Germany). Medium 199, FCS, HBSS, trypsin-EDTA solution, Hepes, and antibiotics were from Gibco (Karlsruhe, Germany) Collagenase (type CLS II) was purchased from Worthington Biochemical Corp. (Freehold, NJ). H202 was from Merck (Darmstadt, Germany). Gelatin from porcine skin type I, cholera toxin, forskolin, PGE,, and catalase were purchased from Sigma Chemical Co., Munich, Germany). The two cyclic adenosine monophosphorothioates Sp-cAMPS and Rp-cAMPS were a gift of Sandoz Research Institute (East Hanover, NJ). 4-( 3'-cyclopentyl-oxy-4'-methoxyphenyl)-2-pyrrolidone (rolipram) was kindly provided by Schering AG, (Berlin). 4,5-dihydro-6-(4-( lH-imidazol-l-yl)-2-thienyl)-5-methyl-3-(2H)-pyridazinone (motapizone) and 2-O-propoxyphenyl-8-azapurine-6-one (zaprinast) were kindly provided by Rhone-Poulenc Rorer GmbH (Cologne, Germany). 6-(difluormethoxy-3-methoxyphenyl)-3-(2H)-pyridazinone (zardaverine) was synthesized by Byk Gulden GmbH (Konstanz, Germany). 'H20 (1 mCi/g) and labeled cyclic nucleotides were obtained from New England Nuclear (Dreieich, Germany). Methyl-'4C-albumin (0.026 mCi/mg) and the '25I-cAMP assay system were from Amersham Buchler (Braunschweig, Germany). Polycarbonate micropore filter membranes (25 mm diameter, S gm pore size) were purchased from Nucleopore GmbH (Tubingen, Germany). All other chemicals used were analytical grade.
Botulinum C2 toxin was prepared and activated as reported previously (11) . Staphylococcus aureus alpha toxin was purified as described by Bhakdi et al. (27) .
Preparation ofendothelial cells. Pulmonary artery endothelial cells were obtained from freshly slaughtered pigs by exposure to 0.1% collagenase for 12-15 min. Endothelial cells were isolated, characterized, maintained, and dispersed as previously described (28) (29) (30) .
All studies performed (permeability, cAMP content, PDE activity, lactate dehydrogenase (LDH) release) were done on endothelial cells in their third passage. In addition, all parameters (except PDE activity) were determined on the same batch of cells. There were, however, differences with respect to matrix (cells on polycarbonate membranes, flasks, or well plates).
Endothelial cell monolayers were grown on polycarbonate filter membranes that were first coated with gelatin, exposed to glutaraldehyde, and sterilized as described ( 10, 11 ) . The coated filter membranes were placed in the bottom of a petri dish, about 2 X 106 cells were seeded on the filter in medium 199/10% FCS and allowed to adhere for 3 h. Additional 10 ml of medium was then added to the petri dish. Thereafter, the monolayers were fed every other day and used 6 d after plating.
Analysis ofendothelial permeability. A confluent filter membrane was mounted in a modified chemotaxis chamber. Hydraulic conductivity of cell monolayers was determined as follows: The upper and lower compartments were filled with HBSS supplemented with 0.25% albumin. One port to the upper compartment is for substitution of filtrated volume and for application ofpressure and one port is for the addition of reagents. The lower compartment of the system is part of a semiclosed perfusion system (total vol = 10 ml). A roller pump provides a flow of 10 ml/min. The circulating fluid drips into a l-ml capillary; the height of the fluid level in this capillary directly corresponds to the volume filtrated through the cell monolayer. A filtrated volume of 10 0,1 can reliably be measured. The entire system is kept at 370C by a heated water bath. A hydrostatic pressure of 10 cm H20 was continuously applied to the upper side of the cell monolayer. The filtration rate across the endothelial monolayer was continuously determined (10, 11) .
Albumin reflection coefficient. For calculation ofthis parameter 100 nCi 3H20 and 100 nCi 14C-albumin were added to the upper compartment. The amount of 3H20 and '4C-albumin in the lower compartment was continuously measured in a radioactivity monitor (Ramona LS-5; Raytest, Heidelberg, Germany) consisting of a flow through cell, a splitter/mixer, and an IBM-PC for data calculation (for details, see references 10 and 11 ). The albumin reflection coefficient (RC) of the endothelial cell monolayer was calculated every 5 min on the basis of 3H20 and '4C-albumin in the upper and lower compartments of the filter system according to the formula: RC = 1 -(A/B X DIC), as outlined ( 10, 11 ) . A and Care the differences (in cpm/ml) of '4C-albumin and 3H20, respectively, in the lower compartment of the system between time points x and x + 5 min, multiplied by the volume of the lower compartment. B and D are the sums (in cpm/min) of '4C-albumin and 3H20, respectively, in the upper compartment at time points x and x + 5 min, divided by 2. Calculation of A/B (C/D) yields the albumin (water) clearance.
Overall cellular cAMP content was measured by a radioimmunoassay using a commercially available 1251 assay system as described (24) .
Endothelials cells were grown in 24-well plates to confluence in complete medium with 20% FCS (about 250,000 cells/well). At the end of the experiments, the medium was aspirated and cells were washed twice with HBSS; buffer contained 0.5 mM isobutyl-methylxanthine to inhibit phosphodiesterase and prevent subsequent cAMP breakdown during cell solubilization and sample processing. Cells were extracted twice with 500 ,d ice-cold 65% ethanol. Extracts were evaporated under a stream of nitrogen at 60'C and dissolved in assay buffer. An aliquot ofthe extracts and ofthe standards were acetylated by addition ofacetic anhydride and triethylamine ( 1:2) to enhance the sensitivity of cAMP detection.
Release of LDH was used as a marker of cytotoxicity. Endothelial cell monolayers grown on the polycarbonate filter membranes were exposed to 1 mM H202 for 90 min. The medium was removed and centrifuged with 8,000 g for 2 min. LDH activity in the supernatant was determined by the colorimetric measurement of the reduction of sodium pyruvate in the presence of NADH as described ( 11 ) . Enzyme release was expressed as the percentage of total enzyme activity liberated from endothelial cells in the presence of 100 gg/ml mellitin (10, 11) .
Assay ofphosphodiesterase. PDE activity was determined as described (23) . A standard reaction mixture containing 40 mM Tris (pH 8.0), 5 mM MgCl2, 0.1 mg/ml BSA and 0.5 MM cyclic nucleotide/3H-labeled cyclic nucleotide (about 50,000 cpm) was used in a total volume of 200 ul. The reaction was initiated by addition of the enzyme solution (5-20 Mg) and was carried out at 370C for 10 min. The reaction was stopped by addition of 50 AL 0.2 M HCl followed by cooling on ice for 10 min. Crotalus atrox snake venom (50 Ml; 1 mg/ml in 0.2 M Tris, pH 8.0) was added. After 10 min incubation at 37°C the reaction was stopped on ice. A 0.2 ml aliquot ofthe assay volume was applied to a small column (Econo; Bio-Rad Labs, Richmond, CA) containing 1 ml QAE-A25-sephadex followed by 2 ml of 30 mM ammonium formate (pH 6.0). The effluent was collected directly in scintillation vials.
Determination of PDE isoenzyme activities. Activities of the five PDE isoenzymes were evaluated directly in the supernatant and particulate fraction ofcell homogenates derived from (with respect to cAMP) determinations and permeability studies, passage-matched endothelial cultures. 3.5 X 10' endothelial cells grown in flasks were washed and scraped into buffer A (20 mM Bis-Tris, 5 mM dithioerythritol, 2 mM EGTA, and 50 mM sodium acetate, 50 ,M phenyl-methylsulfonylfluoride, 5MM pepstatin, 40MuM leupeptin, 20MgM aprotinin, and 2 mM benzamidine). Cells were disrupted by sonication (Branson Sonifier; Branson Instruments, Danburg, CT) three times for 10 s on ice at a power output of 70 W and the homogenate was centrifuged at 100,000 g for 20 min at 4°C. Supernatant and resuspended pellet (i.e., cytosolic and particulate fractions) were used immediately for PDE assay.
Contributions made by PDE III and IV to total PDE activity were determined by quantifying the inhibition of PDE activity in the presence of I MLM motapizone and 10MM rolipram, respectively. PDE I and PDE II fractions oftotal PDE activity were calculated from the activity increase induced by 50 MM calcium chloride/ 15 nM calmodulin or 5 MM cGMP, respectively (simultaneous presence of 1 MM motapizone and 10MM rolipram). PDE V fraction was determined from inhibition induced by 10 MM zaprinast in the presence of 0.5 MM cGMP as substrate. The concentrations of the selective inhibitors that were used blocked > 95% of the activity of the respective PDE isoenzyme.
Experimental protocol. "Sealed" endothelial cell monolayers were used in this study; i.e., monolayers which showed a final hydraulic conductivity of < 5-10* 10 6 cm -s-' * cm H20-' and an albumin RC > 0.65 in the presence of a hydrostatic pressure of 10 cm H20. In all experiments, H202 was added as a bolus into the upper compartment at time 0 and then was infused continuously. Inhibitors were added as a bolus 15 min before H202 and were then infused continuously into the upper compartment. Possible effects of all reagents added on H202 concentration were checked and excluded spectrophotometrically at 230 nmM according to Beers and Sizer (31 ).
Statistical methods. Depending on the number of groups (A) and the number of different time points studied (B), data of Figs. 1-5 and Table I were analyzed by an A x B ANOVA. The data in Table III were analyzed using a one-way ANOVA. Main effects were then compared by an F probability test (32) . Otherwise, data were analyzed by Student's t test for unpaired samples. P < 0.05 was considered significant.
Results
Effect ofH2O2 on endothelialpermeability. Resting endothelial cell monolayers showed a hydraulic conductivity of 2 x 10-6 X s-' X cm H20' and an albumin RC of 0.70-0.75. H202 increased the hydraulic conductivity ofa sealed endothelial cell monolayer dose (0.05-5 mM) and time dependently min). This H202 effect was abolished in the presence of catalase, an enzyme that metabolizes H202 to 02 and H20 (Fig. 1) . Addition of H202 resulted also in a dramatic decrease in the albumin reflecting properties ofthe endothelial cell monolayer (Fig. 2 ). 1 mM H202 was chosen for all subsequent studies using different inhibitors.
Effects ofcAMP-modifying reagents. Preincubation of endothelial cell monolayers for 60 min with 1 pM cholera toxin or more made them resistant to a subsequent H202 exposure while IO-`3 M cholera toxin only slightly reduced H202-induced increase in endothelial permeability (Table I) . 10-50 nM forskolin reduced and 0.1-1 gm forskolin inhibited the effect of H202 on endothelial permeability (Table I) . These results clearly indicated that an activation of adenylate cyclase antagonizes the permeability increasing effect of H202.
PGE1 and isoproterenol, two receptor-operated adenylate cyclase activators, blocked the effects of H202 on endothelial permeability at 10 -4 M (not shown). 5 mM of the membrane permeable cAMP analogue dibutyryl-cAMP were also inhibitory in this system (not shown). 10 nM Sp-cAMPS, a cAMPdependent protein kinase agonist ( 15 ) , blocked H202-induced increase in endothelial permeability (Table I) . Rp-cAMPS, a putative cAMP-dependent protein kinase antagonist ( 15) , was used as a control to Sp-cAMPS. 100 nM Rp-cAMPS were without effect in the experimental system used.
Effects ofPDE inhibitors. Next, PDE III selective motapizone, PDE IV selective rolipram, and PDE III/IV dual selective zardaverine were tested (22-24). The effects of H202 on endothelial permeability were completely inhibited by l0-4 M zardaverine, rolipram, and motapizone (Fig. 3) . A 50% reduction of the hydraulic conductivity was noted by 10-1 M zardaverine, 10-6 M rolipram, and l0-1 M motapizone.
The combination of a receptor-operated stimulus (PGE,) and a PDE inhibitor was tested. When 1 ,M PGE1, which, per se, was slightly inhibitory was used, a complete inhibition of the H202-induced increase in hydraulic conductivity was noted (Fig. 4) . Thus, PGEI increased the effectiveness ofzardaverine by a factor of 10,000 and ofrolipram by a factor of 100, while the effectiveness ofmotapizone remained unchanged. When l0-7 M PGE1 was used zardaverine was completely inhibitory at l0-7 M (instead of 1O-8 M) (data not shown).
The combination of l0-7 M zardaverine and 10-6 M PGE1
prevented the H202-induced increase in hydraulic conductivity (Fig. 4 and Fig. 2, line 1) and, in addition, the H202-induced decrease in the albumin reflection coefficient (Fig. 2, line 2 ). An increased permeability was noted at low concentrations of rolipram (10-7 M), zardaverine ( 10-6 M), or zardaverine (10-9 M)/PGE,. This phenomenon may be related to the known protein kinase A induced phosphorylation and activation of PDE III (33, 34) ; in the presence of low concentrations of a PDE IV or PDE III/IV inhibitor the activity ofthe cAMPdependent protein kinase will increase. PDE III, one target of this reaction, will increase its activity, thereby enhancing overall endothelial cAMP hydrolyzing capacity. Thus, it is conceivable that over a narrow concentration range of PDE-inhibitors cAMP decreases and permeability increases "paradoxically."
Zardaverine plus PGEI ( 10-6 M, each) were effective only when added 5 or 2.5 min before H202 addition (Fig. 5) . A slight reduction in H202-induced endothelial permeability was noted when H202 and treatment ( 10-6 M zardaverine and 10-6 M PGE1 ) were added simultaneously (Fig. 5, line 3) . No "therapeutic" intervention was possible after H202 addition. An increase in endothelial permeability provoked by 10 Ag/ml S. aureus alpha toxin, a transmembrane channel-forming protein (27) , or by 100 ng/ml botulinum C2 toxin, an inhibitor ofactin polymerization ( 11 ), was not blocked by rolipram at a concentration that reduced H202-induced increases in hydraulic conductivity (data not shown). Exposure of endothelial cells to H202 resulted in a rapid decline of cAMP content, which was significant after 5 min (Table III) . Within 10-15 min, cAMP decreased by > 50%. High endothelial cAMP content after preincubation with forskolin fell with similar kinetics after H202 exposure (Table III) .
Pretreatment of endothelial cells with PGEI and zardaverine did also not slow down the H202 induced cAMP fall. The relative rate of cAMP fall was even increased in the cholera toxin/ H202 group (Table III) .
PDE isoenzymes in porcine pulmonary endothelial cells. The PDE isoenzyme profile ofporcine pulmonary artery endothelial cells was analyzed in cytosolic and particulate fractions of cell homogenates. Activity levels of each isoenzyme were quantitated using the selective inhibitors motapizone (PDE III), rolipram (PDE IV), zardaverine (PDE III + IV), zaprinast (PDE V), and the allosteric effectors cGMP (PDE II) and Ca2+/calmodulin (PDE I).
Concentration inhibition curves by zardaverine were monophasic, whereas those of motapizone and rolipram were bipha- sic indicating the presence of PDE III and IV (Fig. 6) . Two-site analysis of the data of the cytosolic fraction revealed an IC50 value for PDE III and IV of 9 nM and 42 MM (13 nM and 65 ,MM in particulate fraction) for motapizone and of 83 MM and 93 nM (110 M M and 110 nM in particulate fraction) for rolipram, respectively (Fig. 6 ). IC50 for zardaverine was 0.3 OM (0.5 gM) in cytosolic (particulate) fraction (Fig. 6 ). Zaprinast Table III [Drug] (log M) Figure 6 . Analysis of PDE isoenzyme specific IC50 values for three different PDE inhibitors. Basal cAMP-hydrolyzing activity present in cytosolic and particulate fractions of endothelial cell lysates was assayed in the presence of 0.5 pM cAMP as substrate. Inhibition of this activity was determined in the presence of increasing concentrations (l0-'-l0-4 M) of zardaverine, motapizone, and rolipram.
Curves were analysed by linear regression using a normal (for zardaverine) or a two-site fitting model (for motapizone and rolipram).
See Results for calculated IC50 values. Data given are the result of one (out of three) representative experiment.
inhibited cGMP-selective PDE V with an IC50 of 0.3 1AM (not shown). The contribution of each PDE isoenzyme made to overall basal cAMP-hydrolyzing activity (3.7 nmol/min per 108 cells in the presence of 0.5 uM substrate) was evaluated (Table IV) : PDE III and IV activities amounted to 1.6 and 1.4 nmol/min per 108 cells. The combination of motapizone and rolipram inhibited the same fraction ofbasal activity as did zardaverine.
Addition of 5 ALM cGMP to cell homogenates which contained rolipram and motapizone or zardaverine almost completely restored cAMP hydrolyzing activity indicating the presence of a cGMP-stimulated PDE that has been termed PDE II, as outlined in Beavo (22). PDE II was the isoenzyme with the highest activity (2.3 nmol/min per 108 cells). No selective PDE II inhibitors are known. Ca2+/calmodulin did not stimulate and zaprinast, a selective PDE V inhibitor, did not reduce cAMP or cGMP hydrolyzing activity, suggesting that porcine pulmonary artery endothelial cells contained negible amounts of PDE subtypes I and V. Fig. 7 , which is based on data of Table IV , presents the distribution of PDE isoenzymes in porcine pulmonary artery endothelial cells. PDE III appeared to be located preferentially in the particulate compartment (74%), whereas PDE IV was localized predominantly in the cytosol (62%). Discussion
Hydrogen peroxide (H202) proved to be a potent mediator of enhanced endothelial permeability. It increased the porosity (1) (2) (3) (4) (5) .
In the present study, endothelial permeability was investigated in the presence of a well defined transendothelial pressure gradient ( 10, 11 ). Under these conditions, resting endothelial cell monolayers displayed a hydraulic conductivity of 2 * 10-6 cm * s-.* cm H20-1 and an albumin reflection coefficient of more than 0.7; i.e., the permeability characteristics of our in vitro system are close to the in situ situation. Activation of adenylate cyclase suppressed H202-induced endothelial permeability. Cholera toxin and forskolin were effective at extremely low (10-12 and 5 X 10-8 M) concentrations. The role of cAMP-dependent effects in regulating endothelial permeability was strengthened by studies with PGE1, a receptor-operated adenylate cyclase activator, and with SpcAMPS, a cAMP-dependent protein kinase agonist. Our observations extend the demonstrated improvement ofbarrier properties in resting endothelial monolayers using norepinephrine, isoproterenol, or iloprost as cyclase activators (13) (14) (15) .
PDE inhibition with motapizone, rolipram, or zardaverine blocked H202-related endothelial permeability at high concentrations ( l0-4 M), suggesting a low basal adenylate cyclase activity in these cells. As anticipated simultaneous adenylate cyclase activation/PDE-inhibition proved to be very potent. In the presence of I uM PGEI, the effectiveness of zardaverine and rolipram increased 10,000 and 100 times, respectively, whereas that of motapizone remained unchanged. Thus, a maximum effect was observed when both isoenzymes (PDE III and IV) were blocked, suggesting that PDE III and IV were actively hydrolysing cAMP under the conditions used, whereas PDE II seemed to be inactive.
An analysis of the PDE isoenzymes in porcine pulmonary artery endothelial cells showed high activities of PDE II, III, and IV. Two previous studies reported on the preparation and identification of PDE isoenzyme II and IV in bovine and porcine aortic endothelial cells (25, 26) . Most ofthe cAMP hydrolytic activity was, similar to the present study, detected in the cytosolic fraction. The identification of PDE III in endothelial cells represents a novel observation. Three quarters of this isoenzyme was detected in the particulate fraction. The discrepancy to previous studies may relate to analytical differences. Our approach used is fast, circumvents much ofthe proteolytic degradation, and compares isoenzyme activities in the cytosolic and particulate compartment at 0.5 ,uM as a substrate concentration.
Adenylate cyclase activation/PDE inhibition potently blocked H202-related enhanced endothelial permeability. This concept was especially effective when endothelial PDE isoenzyme pattern and profile ofPDE inhibitors used were matched. While this concept appears clear, a straight correlation between endothelial cAMP-levels and protection against H202-related enhanced endothelial permeability was missing. Endothelial permeability was low and cAMP high in the presence of cholera toxin or forskolin. Zardaverine and PGE,, however, were protective at concentrations that did not increase detectable cAMP. This poor correlation is probably caused by determination of overall cellular cAMP content. Dependent on intracellular PDE distribution and on mode of adenylate cyclase activation high local subcellular cAMP peaks are likely to occur, as has already been demonstrated in microwave-fixed cells (37) . These cAMP peaks probably are easily missed by global cAMP determinations in cell lysates.
Matters are further complicated by the fact that cAMP levels dropped in H202-exposed endothelial cells by > 50% within 15 min, suggesting that an early cAMP peak is sufficient for providing protection against a H202 bolus. The observation of a H202-induced cAMP decrease made is new but not surprising, since a rapid ATP-fall is a well known phenomenon in H202-poisoned cells (7, 36, 38, 39) . To our opinion, the low substrate concentration most likely explains the cAMP decrease in H202-exposed cells.
The mechanisms ofthe protection against H202-related en- 
